index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

121 Publications avec texte intégral

Open Access

53 %

Mots clés

Auto-immunité Aged Anti-Mi2 Anticorps anti-agalsidase Data integration Antisynthétase Anti-synthetase syndrome COVID-19 Adult Prognosis Inflammatory myopathy Lysosomal storage diseases Anticorps spécifique des myosites Autoantibodies Inborn errors of metabolism Arthritis Antiphospholipid syndrome Biomarqueurs AAV vectors Cytokines Analyses multidimensionnelles Myopathy Amyotrophy Aldosterone Polymyositis Muscle Humans Gene therapy Deep immune profiling Active Interstitial lung disease Cancer Acute Kidney Injury/epidemiology/etiology Fabry disease Animals Aldostérone AAV humoral immunity Biomarker Adeno-associated vector Abnormal movement Autoimmunity Assisted communication devices Male CD8+T cells Auto-antibodies Agalsidase Biopsy Antibody responses Myositis and muscle disease Inflammation Auto‐antibodies Dependovirus/genetics/immunology B-lymphocyte Anti-agalsidase antibodies DM Skeletal muscle Interferon IBM Autoantibody Anti-MDA5 autoantibodies Adeno-associated virus Anti‐mitochondrial antibodies Adeno-associated virus vector Anti-drug antibodies Adjudication Adverse drug reactions Anémie hémolytique Inclusion body myositis Case reports CD8+ T-bet+ cells Autoimmune diseases Dermatomyositis Adolescence Bioelectrical impedance analysis Anti-IgE IgG Myositis Middle Aged Female Myocarditis Sphingosine-1-phosphate Biomarkers AAV vector Antisynthetase Idiopathic inflammatory myopathies IMNM AAV Systems biology Amyotrophic lateral sclerosis Mass cytometry Immunotherapy Machine learning Anti-interleukin-6 Immune checkpoint inhibitors Antisynthetase syndrome AAV antibody Antibodies B cell homeostasis Outcome measures Acid-alpha-glucosidase Multidisciplinarity